Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002367370 | SCV002666866 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-04-21 | criteria provided, single submitter | clinical testing | The c.710_715delTTTATCins14 variant, located in coding exon 4 of the MSH2 gene, results from the deletion of 6 nucleotides and insertion of 14 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.I237Kfs*12). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |